ÂÜÀòÂÒÂ×

Alisar Zahr, PhD has a diverse work experience in research, clinical development, and engineering. From 1998 to 2018, they held roles at Johnson Matthey Pharma Services, Biogen, ALZA Corporation, Penn State University, University of California, Santa Barbara, Santa Barbara Tutors, Schepens Eye Research Institute, Johnson & Johnson, Swiss-American Contract Development and Manufacturing, and Revision Skincare.

At Johnson Matthey Pharma Services, they were an Engineering Intern. At Biogen, they were an Engineer Intern. At ALZA Corporation, they were a Biomedical Engineering Intern. At Penn State University, they were a Graduate Student and worked on fabricating novel targeted drug delivery carriers. At University of California, Santa Barbara, they were a Post-Doctoral Researcher and developed a new method in fabricating flexible particles for drug delivery and imaging technologies. At Santa Barbara Tutors, they were a Tutor. At Schepens Eye Research Institute, they were a Postdoctoral Research Scientist and worked on studying the role of endomucin, a mucin-like glycoprotein, in anti-adhesion and anti-inflammation. At Johnson & Johnson, they were a Principal Scientist, Technology Formulations, a Principal Scientist, Product Development Sun Care, and a Senior Scientist of Technical Transfer for New Product Deployment. At Swiss-American Contract Development and Manufacturing, they were a Director, New Technologies and built and implemented strategies for short term and long term pipelines. At Revision Skincare, they are a Senior Director of Research and Clinical Development, a Director of Research and Clinical Development, and a Clinical Science Liaison.

Alisar Zahr, PhD received their PhD in Chemical Engineering from Penn State University in 2007, and their BS in Chemical Engineering from Villanova University in 2002.